NDC 85006-1754-1

ALYMSYS 100 mg/4mL

bevacizumab-maly · INJECTION, SOLUTION

No Recall History

Alymsys (bevacizumab-maly) is a prescription injection given intravenously to treat certain cancers by blocking blood vessel growth that supplies tumors. It is a biosimilar version of bevacizumab, a medication used in combination with chemotherapy or other cancer treatments.

Key Facts

Brand Name: ALYMSYS
Generic Name: bevacizumab-maly
NDC Code (Package): 85006-1754-1
NDC Code (Product): 85006-1754
Manufacturer: Valorum Biologics, LLC
Strength: 100 mg/4mL
Dosage Form: INJECTION, SOLUTION
Route: INTRAVENOUS
Marketing Status
Application #: BLA761231
Marketing Start: 03/30/2026

Recall History

No Recall History

View Full Drug Page

ALYMSYS — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.